TENDENCIES OF THE MORTALITY RATES FROM ESOPHAGEAL CANCER IN THE EU COUNTRIES AND UKRAINE
Summary. In this article the problems of the prevalence of esophageal cancer and the distribution of mortality rates from this disease are considered in EU countries. The rates of mortality from esophageal cancer are analyzed by statistical methods and time series analysis. A study is carried out of the features of the tendencies of mortality rates from esophageal cancer in six EU countries and in Ukraine. It is emphasized that various factors, such as the environmental situation, socio-demographic characteristics of the population, culture and nature of nutrition, the general health status of the population, the availability of resources and the level of healthcare in the region should be took into account for development of the programmes for the prevention of prevalence of esophageal cancer. By means of the models for time series analysis we forecast the rates of mortality from esophageal cancer for six countries of EU and for Ukraine, which can be used for the development of the national strategies to reduce the prevalence and mortality from esophageal cancer.
2. Cancer Trends No.8. Cancers of oesophagus and stomach. March 2011. Available from: www.ncri.ie
3. Castellsague X, Munoz N, De Stefani E, Victora CG, Castelletto R, Rolon PA et al. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in males and females. Int. J. Cancer. 1999; 82 (5). pp. 57–64.
4. Dušek L, Mužík J, Kubásek M, Koptíková J, Žaloudík J, Vyzula R. The Czech national web portal of cancer epidemiology [online]. Masaryk University, , 26.3.2007 [cit. 2007-3-26]. Incidence and mortality C15 – malignant neoplasm of esophageal, time trend 1977–2002. Available from: URL:http://www.svod.cz.
5. Kollarova H., Machova L., Horakova D., Janoutova G., Janout V. Epidemiology of esophageal cancer – an overview article. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007, 151(1). Pp.17–28. 17.
6. Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 1999; pp. 25–31.
7. Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am. J. Gastroenterol. 2008; pp.94–99.
8. Lindblad M, Rodriguez LA, Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia and gastric non-cardia adenocarcinoma among males and females in nested case-control study. Cancer Causes Control 2005; 16(3):2. pp. 85–94.
9. Pennathur A, Farkas A, Krasinskas AM, et al. Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann. Thorac Surg. 2009; pp. 48–55.
10. Polednak AP. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int. J. Cancer 2003; pp. 98–100.
11. WHO statistics database. Available at: http://apps.who.int/healthinfo/statistics/mortality/whodpms/params_ex.php; https://moffitt.org/cancers/esophageal-cancer/faqs/what-environmental-factors-contribute-to-your-risk-of-esophageal-cancer/